Relative reactivity of N,N-donor ligands in substitution reactions of cis-diaqua(2-aminomethylpiperidine)platinum(II): a detailed kinetic and mechanistic study

[1] Esposito BP(2002)Interactions of antitumoral platinum-group metallodrugs with albumin Coord. Chem. Rev. 232 137-1022

[2] Najjar R(2003)Platinum-based anticancer agents: Innovative design strategies and biological perspectives Med. Res. Rev. 23 633-undefined

[3] Ho YP(2006)Platinum group antitumor chemistry: design and development of new anticancer drugs complementary to cisplatin Curr. Med. Chem. 13 1337-undefined

[4] Au-Yeung SCF(1999)New Steric Hindrance Approach Employing the Hybrid Ligand 2-Aminomethylpiperidine for Diminishing Dynamic Motion Problems of Platinum Anticancer Drug Adducts Containing Guanine Derivatives Inorg. Chem. 38 777-undefined

[5] To KKW(2003)Conformation of 2-Aminomethylpyrrolidine and 2-Aminomethylpiperidine in Ternary Platinum(II) Complexes: Regulation of Conformation of the Diamine by the Coexisting Ligand Chem. Pharm. Bull. 51 1157-undefined

[6] Abu-Surrah AS(1988)Crystal and molecular structure of cis- J. Am. Chem. Soc. 110 7368-undefined

[7] Kettunen M(1990), the principal adduct formed by cis-diamminedichloroplatinum(II) with DNA J. Am. Chem. Soc. 112 8177-undefined

[8] Wong HC(1998)Stereochemically controlled ligands influence atropisomerization of platinum(II) nucleotide complexes. Evidence for head-to-head and stable.LAMBDA. head-to-tail atropisomers J. Coord. Chem. 44 109-undefined

[9] Coogan R(1974)Synthesis of a new glyoxime derivative, characterization and investigation of its complexes with Ni (II), Co (II), Cu (II) and Coord. Chem. Rev. 13 1-undefined

[10] Intini FP(2002) (VI) metals Trans. Met. Chem 27 877-undefined

[1] Esposito BP(2002)Interactions of antitumoral platinum-group metallodrugs with albumin Coord. Chem. Rev. 232 137-1022

[2] Najjar R(2003)Platinum-based anticancer agents: Innovative design strategies and biological perspectives Med. Res. Rev. 23 633-undefined

[3] Ho YP(2006)Platinum group antitumor chemistry: design and development of new anticancer drugs complementary to cisplatin Curr. Med. Chem. 13 1337-undefined

[4] Au-Yeung SCF(1999)New Steric Hindrance Approach Employing the Hybrid Ligand 2-Aminomethylpiperidine for Diminishing Dynamic Motion Problems of Platinum Anticancer Drug Adducts Containing Guanine Derivatives Inorg. Chem. 38 777-undefined

[5] To KKW(2003)Conformation of 2-Aminomethylpyrrolidine and 2-Aminomethylpiperidine in Ternary Platinum(II) Complexes: Regulation of Conformation of the Diamine by the Coexisting Ligand Chem. Pharm. Bull. 51 1157-undefined

[6] Abu-Surrah AS(1988)Crystal and molecular structure of cis- J. Am. Chem. Soc. 110 7368-undefined

[7] Kettunen M(1990), the principal adduct formed by cis-diamminedichloroplatinum(II) with DNA J. Am. Chem. Soc. 112 8177-undefined

[8] Wong HC(1998)Stereochemically controlled ligands influence atropisomerization of platinum(II) nucleotide complexes. Evidence for head-to-head and stable.LAMBDA. head-to-tail atropisomers J. Coord. Chem. 44 109-undefined

[9] Coogan R(1974)Synthesis of a new glyoxime derivative, characterization and investigation of its complexes with Ni (II), Co (II), Cu (II) and Coord. Chem. Rev. 13 1-undefined

[10] Intini FP(2002) (VI) metals Trans. Met. Chem 27 877-undefined